Omalizumab Linked to Greatest Rate of Hypersensitivity Reactions in Atopic Diseases
Valerie Jaroenpuntaruk, MD Credit: the Mayo Clinic A retrospective cohort study, presented at the 2025 American Academy of Allergy, Asthma, & Immunology (AAAAI) annual meeting in San Diego from February 28 – March 8, reported the severity and the prevalence of hypersensitivity reactions to specific biologics for atopic diseases.1 Biologics have transformed the treatment of … Read more